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PURPOSE. The unfolded protein response (UPR) is believed to play a role in the pathogenesis of
Fuchs’ endothelial corneal dystrophy (FECD). The purpose of this study was to investigate
whether unfolded proteins accumulate in the corneal endothelium in FECD and if they are
involved in triggering cell death.
METHODS. Descemet’s membranes with corneal endothelial cells (CECs) were obtained during
keratoplasty, and expression of aggresomes, type 1 collagen, fibronectin, and agrin was
evaluated. Endoplasmic reticulum (ER) stress of immortalized human CECs from non-FECD
subjects and from FECD patients (iHCEC and iFECD, respectively) were evaluated. The effect
of MG132-mediated aggresome formation on the UPR and intrinsic pathway and the effect of
mitochondrial damage on UPR were also examined. The effect of CHOP knockdown on the
ER stress–mediated intrinsic pathway was also evaluated.
RESULTS. Aggresome formation was higher in iFECD than in iHCEC and was colocalized with
type 1 collagen, fibronectin, and agrin. GRP78, phosphorylated IRE1, PERK, and CHOP
showed higher activation in iFECD than in iHCEC. MG132-mediated aggresome formation
upregulated ER stress sensors, the mitochondrial membrane potential drop, cytochrome c
release to the cytoplasm, and activation of caspase-9 and -3. By contrast, staurosporine-
mediated mitochondrial damage did not induce ER stress. Knockdown of CHOP attenuated
the ER stress-induced cleavage of caspase-9, which is caused by intrinsic pathway activation.
CONCLUSIONS. Excessive synthesis of extracellular matrix proteins induced unfolded protein
accumulation in FECD. Prolonged ER stress–mediated cell death, occurring via the intrinsic
apoptotic signaling pathway, therefore might be associated with the pathogenesis of FECD.
Keywords: Fuchs’ endothelial corneal dystrophy, unfolded protein response, apoptosis,
corneal endothelial cells
Fuchs’ endothelial corneal dystrophy (FECD) is a bilateral andslowly progressive primary disease of the corneal endothe-
lium. It is clinically categorized into three stages: (1) the
presence of guttae without corneal edema, (2) the presence of
guttae with stromal or epithelial edema, and (3) corneal
scarring or neovascularization caused by long-standing corneal
edema. The prevalence of FECD in the United States has been
estimated to be as high as 4% of the population older than 40
years.1 In agreement with this high prevalence, visual
disturbance due to FECD is the leading cause of corneal
transplantation. Recent data show that 15,707 (21.7%) of the
72,465 corneas provided by eye banks in the United States were
used to treat FECD.2
Histological analysis has suggested that the corneal endo-
thelial cell (CEC) loss occurring in FECD is due to apoptosis,3–5
but the pathophysiologic cause of this apoptosis has not been
identified. In 2010, Engler and colleagues6 showed morpho-
logical alterations of the endoplasmic reticulum (ER), and
upregulation of markers of the unfolded protein response
(UPR), such as glucose-regulated protein (GRP78), a subunit of
eukaryotic initiation factor 2 (eIF2a), and CCAAT-enhancer-
binding protein homologous protein (CHOP) in the corneal
endothelium of FECD patients. Hence, they postulated that the
UPR plays an important role in the pathogenesis of FECD.6 The
same research group subsequently showed the involvement of
the UPR in the CEC loss in an alpha 2 collagen VIII transgenic
knock-in mouse, an animal model of early-onset FECD.7
The ER is the membranous tubular network that participates
in cellular protein biosynthesis, lipid biosynthesis, and calcium
homeostasis. Newly synthesized proteins mature and undergo
proper folding in the ER.8 A wide range of stresses, including
increased secretory protein production, glucose deprivation,
and hypoxia, induces the accumulation of unfolded or
misfolded proteins in the ER lumen.9,10 The conditions within
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the ER are monitored by the UPR signaling pathway, and
activation of the UPR restores protein folding homeostasis by
reducing protein translation, increasing ER chaperone expres-
sion, and degrading misfolded proteins.9–11 However, pro-
longed ER stress impairs protein homeostasis, which then
triggers the UPR to induce apoptosis.9,10,12 Consequently,
targeting the UPR has emerged as a promising therapeutic
modality for the treatment of diseases related to accumulation
of unfolded or misfolded proteins in the ER.13–15
Our aim in the present study was to investigate the poten-
tial involvement of the UPR in FECD as a possible contributor
to the underlying pathophysiological mechanism. Here, we
have investigated the accumulation of unfolded or misfolded
proteins in the corneal endothelium with the goal of detecting
any functional links between the UPR and apoptosis of CECs in
FECD.
METHODS
Ethics Statement
The human tissue used in this study was handled under the
guidelines based on the ethical principles of the Declaration of
Helsinki. This study was performed according to a protocol
approved by the ethical review committee of the Friedrich-
Alexander University Erlangen-Nu¨rnberg. Informed consent
was acquired from the patients with FECD, and stripped
Descemet’s membranes with CECs were obtained during
Descemet’s membrane endothelial keratoplasty (DMEK). Nor-
mal human donor corneas were obtained from SightLife
(Seattle, WA, USA; http://www.sightlife.org/). Informed writ-
ten consent was obtained from the next of kin of all deceased
donors with regard to eye donation for research. All tissue
specimens were recovered under the tenets of the Uniform
Anatomical Gift Act of the particular state in which the donor
consent was obtained and the tissue recovered.
Cell Culture
The immortalized CECs from three patients with FECD were
used as a cell model, and the immortalized CECs from three
donor corneas were used as control (hereafter iFECD and
iHCEC, respectively). Both iFECD and iHCEC were passaged
from 30 to 40 times before use in these experiments.
Descemet’s membranes, including the CECs, were stripped
from the corneas of patients with FECD during DMEK and used
for cell cultivation. Three patients with FECD and the three
donors of the non-FECD subject were older than 50 years.
The iFECD and iHCEC were cultured according to
published protocols.16,17 Briefly, the FECD-derived CECs and
the control CEC were cultured for 14–21 days and then
immortalized using SV40 and hTERT to produce iFECD and
iHCEC cell lines, respectively. The coding sequences of the
SV40 large T antigen and hTERT genes were amplified by PCR
and were TA-cloned into a commercial lentiviral vector. The
lentiviral vectors were transfected to human embryonic kidney
293T cells (RCB2202; Riken Bioresource Center, Ibaraki, Japan)
along with three helper plasmids (pLP1, pLP2, and pLP/VSVG)
using a transfection reagent. After 48 hours of transfection, the
supernatant of the culture medium was harvested. For
lentiviral transduction, the virus-containing supernatants of
both genes were added to the cultures of HCECs in the
presence of 5 lg/mL of polybrene. The immortalized cells
were cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Life Technologies Corp., Carlsbad, CA, USA) containing 10%
fetal bovine serum and 1% penicillin and streptomycin (Life
Technologies Corp.). Once the cells were 80% confluent, the
cells were trypsinized with 0.05% Trypsin-EDTA and passaged.
The iHCEC were cultured with DMEM supplemented with
thapsigargin (10 lM; Wako Pure Chemical Industries, Ltd.,
Tokyo, Japan), and tunicamycin (30 lg/mL; Wako Pure
Chemical Industries, Ltd.) to induce ER stress. The iHCEC
were cultured with DMEM supplemented with staurosporine
(0.5 lM; Sigma-Aldrich Corp., St. Louis, MO, USA) to induce
apoptosis via the mitochondrial pathway. Unfolded protein
aggregation was induced with MG132 (0.5 lM; Sigma-Aldrich
Corp.).
Transmission Electron Microscopy (TEM)
Ultrastructural analysis of corneal specimens was performed
on full-thickness corneas obtained during penetrating kerato-
plasty from patients with FECD (n ¼ 5, mean age 63.3 6 7.5
years) to assess whether the morphology of the ER and
mitochondria was altered. Donor corneas from the non-FECD
subjects were evaluated as a control. The central corneal
endothelium was evaluated in FECD and in non-FECD
subjects. Tissue specimens were fixed in 2.5% glutaraldehyde
in 0.1 M phosphate buffer, postfixed in 2% buffered osmium
tetroxide, dehydrated in graded alcohol concentrations, and
embedded in epoxy resin, according to standard protocols.
For analysis of cultured CECs, 13 105 cells were seeded onto
Corning Transwell polyester membrane cell culture inserts
(Corning, Inc., Corning, NY, USA) and grown until confluent.
The entire Transwell inserts were fixed with 2.5% glutaralde-
hyde, 2% paraformaldehyde in 0.1 M Sorensen phosphate
buffer. The Transwell membrane samples were washed in 0.1
M Sorensen phosphate buffer, processed through 0.5% uranyl
acetate for en bloc staining, and subsequently dehydrated
using an ascending ethanol series. The specimens were
transferred to propylene oxide and then infiltrated and
embedded in Araldite CY212 resin. Ultrathin sections were
collected on uncoated G300 copper grids and stained with 1%
aqueous phosphotungstic acid and uranyl acetate. Sections
were examined with a transmission electron microscope
(JEOL 1010; JEOL, Tokyo, Japan) equipped with a charge-
coupled device camera (Orius SC1000; Gatan, Pleasanton, CA,
USA).
Immunocytochemistry and Aggresome Staining
Descemet’s membranes with CECs, obtained from 21 FECD
patients during DMEK or from donor corneas from 20 non-
FECD control subjects, and cultured CECs were fixed with 4%
paraformaldehyde at room temperature for 10 minutes on
glass slides. Excess paraformaldehyde was removed by
washing with Dulbecco’s PBS, and the samples were
permeabilized with 0.5% Triton X-100 (Nacalai Tesque, Kyoto,
Japan), and then incubated with 1% BSA to block nonspecific
binding. The samples were incubated with primary antibodies
against GRP78 (1:200; Santa Cruz Biotechnology, Santa Cruz,
CA, USA), collagen I (1:200; Sigma-Aldrich Corp.), fibronectin
(1:200; BD Biosciences, San Jose, CA, USA), agrin (1:200;
Santa Cruz Biotechnology), and CHOP (1:200; Santa Cruz
Biotechnology). Alexa Fluor 488-conjugated goat anti-mouse
(Thermo Fisher Scientific, Waltham, MA, USA) antibodies
were used as secondary antibodies at a 1:1000 dilution. For
aggresome staining, samples were incubated with aggresome
reagent (1:2000; Enzo Life Science Inc., Farmingdale, NY,
USA) for 60 minutes. Nuclei were stained with 4 0,6-diamidino-
2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA,
USA). The slides were examined with a fluorescence
microscope (DM 2500; Leica Microsystems, Wetzlar, Ger-
many).
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Quantitative Real-Time PCR
Gene expression levels were analyzed using TaqMan real-time
PCR. Total RNA was extracted from the corneal endothelium
from 10 patients with FECD and 10 donor corneas using the
miRNeasy Mini Kit (Qiagen, Hilden, Germany). Then, cDNA
was synthesized by SuperScript VILO MasterMix (Thermo
Fisher Scientific). For quantification, standard curves using
serial dilutions (102–107 copies) of plasmid-cloned amplicons
were run in parallel. For normalization of gene expression
levels, ratios relative to glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) were calculated.
TheTaqManprimersusedwere forCOL1A1,Hs00164004_ml;
FN1, Hs00365052_ml; AGRN, Hs00394748_ml; and TaqMan
predevelopment human GAPDH (Applied Biosystems, Foster
City, CA, USA). The PCR was performed using the StepOne
(Applied Biosystems) real-time PCR system. GAPDH was used
as an internal standard.
Mitochondrial Membrane Potential
The iFECD and iHCEC were stained with 5,50,6,60-tetrachloro-
1,1 0,3,3 0-tetraethylbenzimidazolylcarbocyanine iodide (JC-1)
and the mitochondrial membrane potential was evaluated by
fluorescence microscopy and flow cytometry, according to the
manufacturer’s protocol. Briefly, iFECD and iHCEC were
cultured in medium supplemented with carbonyl cyanide-m-
chlorophenylhydrazone (CCCP) (50 lM; Abcam, Cambridge,
UK) for 9 hours as positive controls. For fluorescence
microscopy analysis, the cells were incubated with MitoScreen
(10 lM; BD Biosciences) for 15 minutes and fixed with 4%
formaldehyde for 10 minutes, washed with PBS, and nuclei
were stained with DAPI. The slides were examined with a
fluorescence microscope (DMI 4000B; Leica Microsystems,
Wetzlar, Germany). For flow cytometry, cells were washed
twice with PBS and incubated with Accumax (Innovative Cell
Technologies, San Diego, CA, USA) for 10 minutes at 378C. The
cells were recovered in Assay buffer supplemented with
MitoScreen (10 lM; BD Biosciences), incubated for 15 minutes
at 48C, washed three times with PBS, and then resuspended in
FACS buffer and analyzed by flow cytometry using CellQuest
Pro software (BD Biosciences).
Immunoblotting
The cultured CECs were washed with ice-cold PBS and lysed
with ice-cold RIPA buffer containing phosphatase inhibitor
cocktail 2 (Sigma-Aldrich Corp.) and protease inhibitor cocktail
(Roche Applied Science, Penzberg, Germany). Following
centrifugation, the supernatant containing the total proteins
was fractionated by SDS-PAGE. The separated proteins were
transferred to polyvinylidene difluoride membranes, blocked
with 3% nonfat dry milk, and incubated overnight at 48C with
the following primary antibodies: pancreatic ER kinase (PERK)
(1:1000; Cell Signaling Technology, Inc., Danvers, MA, USA),
phosphorylated PERK (1:1000; Cell Signaling Technology,
Inc.), activating transcription factor 6a (ATF6a) (1:1000; Bio
Academia, Inc., Osaka, Japan), inositol-requiring transmem-
brane kinase/endonuclease 1a (IRE1a) (1:1000; Cell Signaling
Technology), phosphorylated IRE1a (1:1000; Novus Biologi-
cals, Littleton, CO, USA), spliced active form of X-box binding
protein 1 (XBP1s) (1:1000; BioLegend, San Diego, CA, USA),
bcl2 (1:1000; Cell Signaling Technology), caspase-9 (1:1000;
FIGURE 1. Accumulation of aggresomes in the corneal endothelium of FECD patients. (A) Corneal endothelium was evaluated by TEM.
Representative TEM of non-FECD subject is shown as a control (left). Representative TEM of patients with FECD shows that ER is evident with
morphological change with dilation in the corneal endothelium (middle). The morphology of the mitochondria is also altered and some
mitochondria are dilated (right). Asterisks indicate ER, and arrowheads indicate mitochondria. (B) Descemet’s membranes with corneal
endothelium were obtained during DMEK, and stained for aggresomes and GRP78. Donor corneas were used as controls. A representative
aggresome staining image shows diffuse staining and aggregations in the FECD but not in the control sample. Expression of GRP78 was higher in
FECD samples and widely colocalized with aggresomes. Experimental findings were confirmed in at least 10 independent samples. Nuclei were
stained with DAPI. Scale bar: 20 lm.
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Cell Signaling Technology), caspase-3 (1:1000; Cell Signaling
Technology), poly (ADP-ribose) polymerase (PARP) (1:2000;
Cell Signaling Technology), CHOP (1:1000; Cell Signaling
Technology), cytochrome c (BD Biosciences), voltage-depen-
dent anion channel (VDAC; Cell Signaling Technology), and
GAPDH (1:3000; Medical and Biological Laboratories Co., Ltd.,
Aichi, Japan). The blots were probed with horseradish
peroxidase–conjugated secondary antibodies (1:5000; GE
Healthcare, Piscataway, NJ, USA), developed with luminal for
enhanced chemiluminescence using the ECL Advanced West-
ern Blotting Detection Kit (Nacalai Tesque), and documented
with an LAS4000S (Fuji Film, Tokyo, Japan) cooled charge-
coupled-device camera gel documentation system. The relative
density of immunoblot bands was determined using ImageJ
software (http://imagej.nih.gov/ij/; provided in the public
domain by the National Institutes of Health, Bethesda, MD,
USA). Molecular weight markers (Bio-Rad, Hercules, CA, USA)
were run alongside all samples.
For the assessment of release of cytochrome c from
mitochondria to the cytoplasm, 5 3 105 iHCEC were seeded
on a 10-cm culture dish, cultured for 24 hours, and then
further incubated with fresh DMEM supplemented with
thapsigargin (10 lM) tunicamycin (30 lg/mL), or MG132 for
24 hours. Cytoplasmic protein was isolated from mitochondrial
protein by Mitochondria Isolation Kit (Thermo Fisher Scientif-
ic) according to manufacturer’s protocol. Briefly, harvested
cells were centrifuged at 800g, Mitochondria Isolation Reagent
A was added to the tube, and the sample was stored on ice for
FIGURE 2. Involvement of ECM proteins and proteoglycan in the formation of aggresomes. (A, C, E) Total RNA was extracted from the corneal
endothelium of the 30 patients with FECD and 30 donor corneas. Expression of type 1 collagen, fibronectin, and agrin in the corneal endothelium
was determined by quantitative PCR. The mRNA expression of type 1 collagen, fibronectin, and agrin was significantly higher in FECD than in the
control. *P < 0.01. (B, D, F) Immunofluorescence staining showed that type 1 collagen, fibronectin, and agrin were more highly expressed in FECD
than in control samples. Not all, but a certain amount of type 1 collagen, fibronectin, and agrin, was colocalized with aggresomes. Experimental
findings were confirmed in at least 10 independent samples. Nuclei were stained with DAPI. Scale bar: 20 lm.
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FIGURE 3. Accumulation of aggresomes and mitochondrial membrane depolarization in the FECD cell model. (A) The immortalized CECs from
FECD patients (hereafter iFECD) were used as a cell model, and the immortalized CECs from donor corneas (hereafter, iHCEC) were used as
controls. The iFECD and iHCEC cultured on Corning Transwell polyester membrane cell culture inserts were analyzed by TEM. ER was dilated, and
mitochondria were dilated associated with altered inner structure morphology in iFECD, but not in iHCEC. Asterisks indicate ER, and arrowheads
indicate mitochondria. (B, C) Immunofluorescence staining showed that strong expression of GRP78 and CHOP was observed in iFECD when
compared with iHCEC. Nuclei were stained with DAPI. Experiments were performed on three independent samples. Scale bar: 40 lm. (D) iFECD
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2 minutes. Then, Mitochondria Isolation Reagent B and
Mitochondria Isolation Reagent C were added, and the tube
was centrifuged at 700g. The supernatant was recovered, and
centrifuged again. This final supernatant was recovered as
cytoplasmic protein, and was used for Western blotting.
Knockdown of Genes by Small Interfering RNA
(siRNA)
The iHCEC were seeded into a 24-well plate and cultured until
they reached 50% to 70% confluence. The iHCEC were then
incubated with RNAi duplex (DDIT3) and Lipofectamine
RNAiMAX (Thermo Fisher Scientific), according to the
manufacturer’s protocol. Random RNAi low GC was used as
a control and RT-PCR was performed to assess the knockdown
of DDIT3.
Statistical Analysis
The statistical significance (P value) of differences between
mean values of the two-sample comparison was determined
with the Student’s t-test. The comparison of multiple sample
sets was analyzed using Dunnett’s multiple-comparison test.
The data represent the mean 6 SEM.
RESULTS
Accumulation of Unfolded Proteins in the Corneal
Endothelium of Patients With FECD
Examination of the corneal endothelium of corneas obtained
from FECD patients by TEM frequently showed ultrastructural
alterations of the ER, mainly prominent and dilated ER
cisternae (Fig. 1A; middle) in comparison with the non-FECD
subject (Fig. 1A; left). Morphological alterations observed in
the mitochondria included focal loss of cristae and distended
shape (Fig. 1A; right). These morphological alterations in ER
and mitochondria motivated us to determine the involvement
of ER and mitochondria in the pathophysiology of FECD. We
evaluated the extent of the accumulation of unfolded proteins
in the FECD corneal endothelium. The CEC-Descemet’s
membrane whole mounts demonstrated higher levels of diffuse
aggresome staining and perinuclear aggregations in the FECD
specimens than in the control specimens (Fig. 1B). This
increased expression of aggresomes in FECD samples was
confirmed in all 21 individual Descemet’s membranes. Double
labeling of aggresomes and GRP78, which mediates the protein
folding processes,18 showed higher expression of GRP78 in
FECD samples and a wide colocalization with aggresomes,
suggesting the presence of increased amounts of unfolded or
misfolded protein and subsequent UPR in the endothelial cells
from patients with FECD (Fig. 1B).
We next evaluated the involvement of extracellular matrix
(ECM) components, as these are produced by corneal
endothelium in FECD and accumulate in guttae or thickened
Descemet’s membrane in the form of aggresomes. Similar to
previous reports,19,20 quantitative PCR showed that mRNA
expression of type I collagen, fibronectin, and agrin was higher
in patients with FECD than in controls (Figs. 2A, 2C, 2E;
respectively). Correspondingly, immunofluorescence staining
showed that protein expression of type I collagen, fibronectin,
and agrin was higher in endothelial cells from FECD specimens
than from control specimens. Interestingly, type I collagen,
fibronectin, and agrin were found to partially colocalize with
aggresomes, implying that excessive production of ECM
components contributes to aggresome formation in the
corneal endothelium in FECD (Figs. 2B, 2D, 2F).
Evaluation of the Involvement of the UPR in an
FECD Cell Model
We previously established a cell model of FECD (iFECD) by
culturing and immortalizing the CEC derived from FECD
patients and control CEC derived from donor corneas
(iHCEC).16 Here, we used this model to evaluate the
involvement of the UPR and its effects on mitochondria.
Similar to the findings for surgical specimens, TEM observa-
tions revealed ultrastructural alterations, such as dilated ER
cisternae and swollen mitochondria with partial loss of cristae,
in iFECD but not in iHCEC (Fig. 3A). Asterisks indicate the ER,
and arrowheads indicate mitochondria. Immunofluorescence
microscopy showed higher expression levels of GRP78 and
CHOP (an apoptosis inducer that is activated by ER stress) in
iFECD than in iHCEC (Figs. 3B, 3C, respectively). Aggresome
staining showed higher amounts of unfolded protein associated
with aggregation in iFECD than in iHCEC (Fig. 3D).
These cells were then characterized for expression of three
proximal sensors of the UPR: PERK, IRE1a, and ATF6a.21
Treatment of iHCEC with thapsigargin, which acts as an ER
stress inducer by specifically inhibiting the ER Ca2þ-ATPase,22
increased the phosphorylation of PERK, the cleavage of ATF6,
and the phosphorylation of IRE1. IRE1a is a protein kinase that
initiates unconventional splicing of Xbp-1 mRNA to produce an
active transcription factor,21 and Western blotting showed that
XBP1 expression was induced by thapsigargin stimulation (Fig.
3E; Supplementary Fig. S1). These results provide evidence
that the UPR sensors, PERK, IRE1a, and ATF6a, are conserved
in corneal endothelium to sense the ER stress. Consistent with
the immunofluorescence images shown in Figures 3B and 3C,
Western blotting showed that expression of GRP78 and CHOP
was higher in iFECD than in iHCEC. We also evaluated the
activation of IRE1a and PERK, which induces apoptosis due to
ER stress, and showed that phosphorylation of PERK and of
IRE1a was higher in iFECD than in iHCEC (Fig. 3F). Consistent
and iHCEC were cultured on culture plates and examined for formation of aggresomes. A high level of aggresome formation was observed in iFECD,
but not in iHCEC. Nuclei were stained with DAPI. Experiments were performed on three independent samples. Scale bar: 50 lm. (E) The iHCEC
established from donor corneas were cultured and stimulated with thapsigargin to induce ER stress. Western blotting showed that thapsigargin
treatment induced the phosphorylation of PERK, cleavage of ATF6, and phosphorylation of IRE1 associated with XBP1 cleavage. The relative density
of immunoblot bands in triplicate experiments was determined using ImageJ software. Relative fold differences were compared with the values at 0
hour. (F) Activation of ER stress–related proteins in iHCEC and iFECD was evaluated by Western blotting. Expression of GRP78, phosphorylated
IRE1a and PERK, and CHOP was higher in iFECD than in iHCEC. The relative density of immunoblot bands was determined using ImageJ software.
Experiments were performed using two iHCEC established from two independent non-FECD donor corneas and two iFECD established from two
independent FECD donors. (G) JC-1 staining showed greater depolarization of the mitochondrial membrane potential in iFECD than in iHCEC.
Nuclei were stained with DAPI. Experiments were performed on three independent samples. Scale bar: 50 lm. (H) Flow cytometry also showed
greater depolarization of the mitochondrial membrane potential in iFECD than in iHCEC. Red dots indicate cells with normal mitochondrial
membrane potential and green dots indicate cells with depolarized mitochondrial membrane potential. (I) Flow cytometry showed that 15.5% of
iHCEC exhibited depolarization of mitochondrial membrane potential, but 41.7% of iFECD exhibited this depolarization (n¼ 3). Experiments were
performed in triplicate. *P < 0.01.
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FIGURE 4. Involvement of aggresomes in mitochondrial pathway activation. (A) iHCEC were treated with 10 lM MG132 (a proteasome inhibitor),
which reduces the degradation of ubiquitin-conjugated proteins to induce aggresome formation. Scale bar: 50 lm. (B) iHCEC were treated with
MG132 or 10 lM thapsigargin as positive controls for 24 hours. Western blotting showed that MG132 treatment upregulated expression of GRP78,
phosphorylation of IRE1a, and expression of PERK. The relative density of immunoblot bands in duplicate experiments was determined using
ImageJ software. Relative fold differences were compared with the values of the control. (C) iHCEC were stimulated with CCCP, thapsigargin, and
MG132, followed by evaluation of the mitochondrial membrane potential by JC-1 staining. Thapsigargin-mediated ER stress decreased mitochondrial
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with the morphological alterations of mitochondria observed
with TEM, JC-1 staining showed greater depolarization of the
mitochondrial membrane potential in iFECD than in iHCEC
(Fig. 3G). Flow cytometry also showed significant greater
depolarization of the mitochondrial membrane potential in
iFECD than in iHCEC (Figs. 3H, 3I), suggesting that mitochon-
drial function is impaired in FECD.
Effect of Aggresome Formation on the UPR and
Mitochondrial Function
We evaluated whether aggresome formation induces the UPR
in CECs by treating iHCEC with the proteasome inhibitor
MG132 in a similar manner to iFECD. Unfolded protein is
degraded by the ubiquitin-proteasome system or folded
properly by chaperone proteins, so even healthy cells will
contain some amount of improperly folded protein. The
MG132 treatment reduced the degradation of ubiquitin-
conjugated proteins and induced aggresome formation in the
iHCEC (Fig. 4A). MG132 treatment also upregulated the
expression of GRP78 and the phosphorylation of IRE1a and
PERK, indicating that MG132-mediated aggresome deposition
induce ER stress (Fig. 4B). JC-1 staining showed that both
thapsigargin-induced ER stress and MG132-mediated aggre-
some formation decreased the mitochondrial membrane
potential. CCCP, a chemical inhibitor of oxidative phosphory-
lation, was used as a positive control (Figs. 4C, 4D).
Cytochrome c is a component of the electron transport chain
in mitochondria and is released from mitochondria into the
cytoplasm during the initiation of apoptosis. Western blotting
showed that the release of cytochrome c to the cytoplasm was
higher in iFECD than in iHCEC (Fig. 4E). As was observed in
iFECD, MG132 induced the release of cytochrome c to the
cytoplasm in a similar manner to that observed with
thapsigargin and tunicamycin, which both induce ER stress
(Fig. 4F). Staurosporine was used as positive control (Fig. 4F).
MG132 treatment suppressed the expression of Bcl-2, an
integral outer mitochondrial membrane protein that blocks
apoptotic cell death, and induced the cleavage of caspase-9, a
proapoptotic protein activated by cytochrome c. In addition,
MG132 treatment activated the execution caspase, caspase-3,
as well as the downstream apoptosis-inducing molecule, PARP
(Fig. 4G; Supplementary Fig. S2).
Mechanism of Mitochondrial Apoptotic Pathway
Activation by ER Stress
Staurosporine-mediated mitochondrial damage induced the
cleavage of caspase-9 and the subsequent activation of
caspase-3 and PARP. This cascade of events is well recognized
as the intrinsic apoptotic pathway in a wide range of cell types
(Fig. 5A). We next examined CHOP, which is activated during
chronic UPR by PERK and its downstream signal, and
represents a transcription factor that regulates proapoptotic
genes. Western blotting showed that treatment with thapsi-
gargin, tunicamycin, and MG132 upregulated CHOP together
with chaperone protein, but these responses were not
observed following staurosporine treatment (Fig. 5B). Thapsi-
gargin upregulated CHOP and activated caspase-9, whereas
knockdown of CHOP by siRNA attenuated the downregulation
of caspase-9 cleavage (Fig. 5C). The upregulation of GRP78
induced by thapsigargin was not altered by knockdown of
CHOP.
Correspondingly, JC-1 staining showed that reduction of
mitochondrial membrane potential by thapsigargin was pre-
vented by siRNA-mediated knockdown of CHOP (Fig. 5D).
These data suggest that activation of CHOP by the UPR triggers
the intrinsic pathway associated with the alterations in both
mitochondrial morphology and function. Based on these data,
we proposed that excessive production of ECM proteins,
including type I collagen and fibronectin, causes aggregation of
unfolded or misfolded proteins and subsequent induction of
the UPR. This UPR activation, in turn, triggers a cascade of
molecular events that lead to apoptotic cell death by activation
of the intrinsic apoptotic pathway (Fig. 5E).
DISCUSSION
Prolonged UPR activation, caused by unmitigated ER stress and
impaired homeostasis, induces cell death.9,10,12 Following an
impairment of homeostasis, the UPR serves as an apoptosis
executor. This phenomenon has been accepted as indicating
that the function of UPR-mediated apoptosis is to protect the
organism from damaged cells that cannot ascertain the normal
signaling components.9 The ‘‘life or death’’ decision by the
UPR serves as a universal underlying mechanism in the
pathogenesis of various diseases, including neurodegenerative
diseases, inflammation, metabolic disorders, liver dysfunction,
and cancer.9,10,13 For instance, accumulating evidence now
supports a linkage of protein misfolding and inclusion body
formation with neurodegenerative diseases, such as Alz-
heimer’s disease, Parkinson’s disease, and Huntington’s dis-
ease.23–26 In the field of eye disease, misfolded proteins and
subsequent UPR signaling are related to pathogenesis in certain
types of retinitis pigmentosa and Stargart-like macular degen-
eration.27
In the current study, we showed that excessive ECM
proteins form aggregations of unfolded proteins in the corneal
endothelium of FECD patients. The phenotypic clinical
membrane potential, and MG132-mediated aggresome formation also decreased mitochondrial membrane potential. CCCP, a chemical inhibitor of
oxidative phosphorylation, was used as a positive control for mitochondrial membrane potential depolarization. Experiments were performed in
triplicate. Nuclei were stained with DAPI. Scale bar: 50 lm. (D) iHCEC were stimulated with CCCP, thapsigargin, and MG132, incubated in JC-1
staining reagent, and then evaluated for mitochondrial membrane potential by flow cytometry. Thapsigargin increased the depolarization of iHCEC
mitochondria to 11.2% and MG132 increased this to 21.2%, whereas untreated control iHCEC depolarized at 5.6% (n ¼ 3). Experiments were
performed in triplicate. *P < 0.01. (E) Release of cytochrome c from the mitochondria to the cytoplasm in iHCEC and iFECD was evaluated by
Western blotting. Staurosporine was used as a positive control. Release of cytochrome c from the mitochondria to the cytoplasm was higher in
iFECD than in iHCEC. The relative density of immunoblot bands was determined using ImageJ software. Experiments were performed by using two
iHCEC established from two independent non-FECD donor corneas and two iFECD established from two independent FECD donors. (F) iHCEC
were treated with staurosporine, thapsigargin, tunicamycin, and MG132. Staurosporine was used as a positive control, and it induced the release of
cytochrome c from the mitochondria to the cytoplasm. Staurosporine, thapsigargin or tunicamycin caused ER stress and induced the release of
cytochrome c. MG132-mediated aggresome formation also induced cytochrome c release. GAPDH was used as a cytoplasmic marker, and VDAC was
used as a mitochondrial marker. The relative density of immunoblot bands in duplicate experiments was determined using ImageJ software. Relative
fold differences were compared with the values of the control. (G) Western blotting showed that MG132 suppressed the expression of Bcl-2 and the
cleavage of caspase-9, caspase-3, and PARP, as observed following thapsigargin- or tunicamycin-mediated ER stress. The relative density of
immunoblot bands in triplicate experiments was determined using ImageJ software. Relative fold differences were compared with the values of
control. Experiments were performed in triplicate.
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FIGURE 5. Involvement of CHOP as a ‘‘communicator’’ between the ER and the mitochondria during apoptosis. (A) iHCEC were cultured and then
stimulated with staurosporine. Western blotting showed that staurosporine-mediated mitochondrial damage induces cleavage of caspase-9, caspase-
3, and PARP. The relative density of immunoblot bands in duplicate experiments was determined using ImageJ software. Relative fold differences
were compared with the values of the control. (B) iHCEC were treated with staurosporine, thapsigargin, tunicamycin, and MG132. Western blotting
showed that thapsigargin, tunicamycin, and MG132 upregulated CHOP and GRP78. However, staurosporine did not upregulate CHOP. The relative
density of immunoblot bands in duplicate experiments was determined using ImageJ software. Relative fold differences were compared with the
values of the control. (C) iHCEC were incubated with RNAi duplex (DDIT3) and CHOP was knocked down. Thapsigargin increased CHOP and
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features of FECD are corneal guttae that are excrescences of
the Descemet’s membrane. Earlier studies demonstrated that
certain types of ECM proteins and proteoglycans accumulate
and form the guttae and thickening of Descemet’s mem-
brane.19,20,28 Consistent with the general understanding that
increased secretory protein production can trigger the
formation of unfolded proteins in the ER lumen,9 these
accumulated proteins form aggregations of unfolded proteins
in the FECD corneal endothelium. Although speculative, this
idea may explain the clinical features, in which accumulation
of ECM proteins is accompanied by a gradual loss of the
corneal endothelium. We recently reported that high expres-
sion of genes inducing the epithelial mesenchymal transition
(EMT) was involved in an excessive production of ECM
proteins through the transforming growth factor (TGF)-b
signaling pathway.16 In addition, we postulated that the
regulation of EMT-related genes, by counteracting this TGF-b
signaling, may suppress the excessive production of ECM
proteins.16 Further study is required to determine whether
suppression of excessive ECM production by inhibition of TGF-
b signaling also represses the UPR; however, modulation of
excessive protein production might be worth investigating as a
therapeutic target for FECD treatment.
Three principal signal transducers (ATF6, PERK, and IRE1)
that sense the protein folding conditions in the ER lumen have
been identified.9,29 Expression of these UPR transducers varies
depending on tissues and cell types, but we have shown that
all three signal transducers are conserved in the corneal
endothelium and are activated by ER stress. ATF6 is expressed
in the ER lumen, and unfolded protein accumulation causes
delivery of ATF6 to the Golgi apparatus, whereas cleavage of
the N-terminal cytosolic fragment results in activation of UPR
target genes.30 Consistently, we demonstrated that GRP78, a
target gene of ATF6,30 is highly expressed in FECD samples.
When IRE1 senses unfolded protein, it cleaves the mRNA
encoding X-box binding protein 1 (XBP1) and induces the
spliced active form of XBP1. XBP1 regulates transcription of
chaperones and ER-associated degradation components.31
PERK phosphorylates itself on sensing ER stress, and
reduces mRNA translation by inactivating eIF2. Inactivation
of eIF2 then increases ATF4, which in turn drives the
expression of its target genes. One of the important target
genes is CHOP, a transcription factor that regulates genes
involved in apoptosis. PERK acts as protector of unfolded
proteins, but it also contributes to cell death when the UPR
reaches a critical level.10,32 In the current study, we showed
that a cell model derived from patients with FECD expressed
higher levels of CHOP and this was associated with unfolded
protein accumulation. In addition, knockdown of CHOP by
siRNA suppressed the induction of the intrinsic apoptotic
pathway by ER stress, indicating that CHOP activation due to
ER stress triggers cell loss.
ER stress is transmitted to mitochondria by stress respon-
sive signaling pathways or by altered transfer of metabolites
such as Ca2þ.10,33 Stress signaling from the ER to mitochondria
results in prosurvival or proapoptotic responses in mitochon-
drial function, depending on the strength of the stress. Chronic
exposure to ER stress reduces mitochondrial respiration and
decreases cellular ATP levels, resulting in increases in Ca2þ in
the mitochondria.34 This subsequently induces mitochondrial
fragmentation and elevation of mitochondrial permeability,
which then initiates the intrinsic apoptotic signaling path-
way.10,35,36 We showed that the ultrastructure of mitochondria
is altered in the corneal endothelium of patients with FECD.
We also demonstrated that ER stress is transmitted to these
mitochondria and initiates intrinsic apoptosis, whereas staur-
osporine-mediated apoptosis associated with dysfunction of
mitochondria does not induce ER stress.
We postulate that the pathophysiology induced by apopto-
sis in response to chronic ER stress plays a central role in the
progressive cell loss associated with FECD. In various cell
types, ER stress affects mitochondrial DNA biogenesis and
increases mitochondrially derived reactive oxygen spe-
cies.35–37 An involvement of mitochondrial dysfunction has
consistently been suggested to play a role in FECD. For
example, mitochondrial DNA damage repair was disturbed,
mitochondrial DNA was degraded,38 and antioxidant and
oxidative stress–related gene expression were altered in
FECD.39
In conclusion, the accumulation of excessive amounts of
ECM proteins in FECD causes the accumulation of unfolded
protein, and this might be associated with cell death through
the intrinsic apoptotic signaling pathway. Further studies are
needed, but inhibiting the intrinsic apoptotic pathway that
arises as a UPR response might be a therapeutic target for FECD
treatment.
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